An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Study sponsor: Praxis Precision Medicines
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-07Estimated
Enrollment · participants50Estimated
Source updated2025-04-03Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.